Skip to main content
ProPhase Labs, Inc. (PRPH)
NASDAQ: PRPH · Real-Time Price · USD
0.611
-0.043 (-6.52%)
At close: Dec 20, 2024, 4:00 PM
0.641
+0.031 (5.05%)
After-hours: Dec 20, 2024, 4:05 PM EST

ProPhase Labs Revenue

ProPhase Labs had revenue of $3.15M in the quarter ending September 30, 2024, a decrease of -62.39%. This brings the company's revenue in the last twelve months to $12.75M, down -79.66% year-over-year. In the year 2023, ProPhase Labs had annual revenue of $44.38M, down -63.81%.

Revenue (ttm)
$12.75M
Revenue Growth
-79.66%
P/S Ratio
0.89
Revenue / Employee
$112,858
Employees
113
Market Cap
14.58M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202344.38M-78.26M-63.81%
Dec 31, 2022122.65M43.61M55.17%
Dec 31, 202179.04M64.53M444.59%
Dec 31, 202014.51M4.64M46.96%
Dec 31, 20199.88M-3.25M-24.76%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
The Oncology Institute 378.93M
Ekso Bionics Holdings 17.68M
ImmunoPrecise Antibodies 17.27M
Nephros 13.55M
Spruce Biosciences 7.10M
Synlogic 2.78M
Innovative Eyewear 1.56M
Traws Pharma 226.00K
Revenue Rankings

PRPH News

More News